The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

The International Prognostic Index and the Follicular Lymphoma International Prognostic Index are widely used for the risk assessment of follicular lymphoma (FL). Although molecular studies have provided insight into the biology of FL, no molecular marker has impacted on treatment stratification. Be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: O'Shea, Derville, O'Riain, Ciarán, Taylor, Claire, Waters, Rachel, Carlotti, Emanuela, MacDougall, Finlay, Gribben, John, Rosenwald, Andreas, Ott, German, Rimsza, Lisa M., Smeland, Erlend B., Johnson, Nathalie, Campo, Elias, Greiner, Timothy C., Chan, Wing C., Gascoyne, Randy D., Wright, George, Staudt, Louis M., Lister, T. Andrew, Fitzgibbon, Jude
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954748/
https://ncbi.nlm.nih.gov/pubmed/18628487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-05-154013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados